Skip to main content

Aggregator

DIP Holding: IPO More or Less 4 Times Oversubscribed

1 week 1 day ago
DIP Holding has raised $529 million in its initial public offering, pricing at 1.12 dirhams a share. The listing is the first in the UAE since the start of the Iran war. Khalid bin Kalban, Chairman of DIP Holding spoke to Bloomberg’s Abeer Abu Omar on Horizons Middle East & Africa ahead of the company’s listing on November 11. (Source: Bloomberg)

BGF Retail Operating Income Up In Q3

1 week 1 day ago
(RTTNews) - BGF Retail Co., Ltd. (282330.KS), a South Korean retail company, on Thursday reported higher operating income in the third quarter of 2026 compared with the previous year.

BGF Retail Operating Income Up In Q3

1 week 1 day ago
(RTTNews) - BGF Retail Co., Ltd. (282330.KS), a South Korean retail company, on Thursday reported higher operating income in the third quarter of 2026 compared with the previous year.

HelloFresh Q3 Revenue Down 11.3% YoY

1 week 1 day ago
(RTTNews) - HelloFresh SE (HFG.F, HFG.DE) reported constant currency revenue of approximately 1.4 billion euros in third quarter of 2026 compared to 1.6 billion euros, a year ago, down 11.3%. The revenue of the Meal Kits segment declined by 13.1% in constant currency and the reve

HelloFresh Q3 Revenue Down 11.3% YoY

1 week 1 day ago
(RTTNews) - HelloFresh SE (HFG.F, HFG.DE) reported constant currency revenue of approximately 1.4 billion euros in third quarter of 2026 compared to 1.6 billion euros, a year ago, down 11.3%. The revenue of the Meal Kits segment declined by 13.1% in constant currency and the reve

CICC's Diao On Wealth Management Business

1 week 1 day ago
Diao Zhihai, Head of International Business of Wealth Management at CICC, discusses the bank's wealth management business following the completion of its acquisitions of Cinda and Dongxing Securities. (Source: Bloomberg)

What OPKO Health (OPK) Said on Its Q3 Earnings Call

1 week 1 day ago
3 Stocks That Wall Street Insiders Can’t Stop BuyingOPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale of BioReference assets to L